Cancer Treatment News and Research

RSS

Researchers identify exosomes as missing link to insulin resistance in type 2 diabetes

Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

21 Sep 2017

New collaboration could lead to novel drugs that address unmet medical needs

Southern Research and the University of Tennessee Health Science Center have formed a partnership to advance promising research that could lead to new drugs that address unmet medical needs.

20 Sep 2017

Increase in physical activity boosts breast cancer survivors’ mental processing speed

It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.

19 Sep 2017

Salk study shows how fast-growing tumors evade immune system

The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor immunity.

18 Sep 2017

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.

18 Sep 2017

Arkansas professor makes strides toward developing enhanced cancer treatment

A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.

13 Sep 2017

Woman's choice of surgeon plays major role in influencing breast cancer treatment choices

A woman's choice of surgeon plays a significant role in whether she's likely to receive an increasingly popular aggressive breast cancer surgery.

13 Sep 2017

Immunotherapy could help some breast cancer patients based on genetic changes in their tumors

Immunotherapy drugs could help some breast cancer patients based on the genetic changes in their tumors, researchers at the Wellcome Trust Sanger Institute and their collaborators find.

13 Sep 2017

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of cancer treatment that causes shooting or burning pain, numbness, tingling and cold sensitivity of the hands and feet for many cancer patients.

13 Sep 2017

Researchers reveal possible origin of cancer-associated fibroblasts

Researchers at Okayama University describe in Scientific Reports that cancer-associated fibroblasts — cells that play a key role in cancer progression — originate from cancer stem cells. Preventing cancer stem cells from transforming into cancer-associated fibroblast may be a promising approach towards cancer treatment.

12 Sep 2017

Study identifies late effects that may interfere with work status of young adult cancer survivors

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

The most complete assessment yet of chronic disease in adult survivors of childhood cancer found they have a nearly two-fold greater cumulative burden of chronic health problems than the general public.

8 Sep 2017

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

Existing drug may one day protect premenopausal women from infertility after cancer treatments

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a new study.

1 Sep 2017

Why one California County went surgery shopping

Retiree Leslie Robinson-Stone and her husband enjoyed a weeklong, all-expenses-paid trip to a luxury resort — all thanks to the county she worked for.

1 Sep 2017

Motorized molecules driven by light to cut into cancer cells

Researchers have developed a novel technique where molecules would be motorized using light and these would be used to drill holes in the membranes of individual cells such as the cancer cells. This could bring the treatment molecule into the cancer cell directly and cause them to die.

31 Aug 2017

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

The Southeast's first comprehensive cancer treatment program at the University of Alabama at Birmingham takes patient care to the next level by improving the lives of women affected by or at risk for ovarian cancer.

31 Aug 2017

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

The American Society for Radiation Oncology has selected 43 recipients to be presented with one of its 2017 Annual Meeting Abstract Awards. These individuals will be recognized for their top-rated research abstracts at ASTRO's 59th Annual Meeting, taking place September 24-27 in San Diego.

31 Aug 2017

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.

31 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Cancer Treatment News and Research

Researchers identify exosomes as missing link to insulin resistance in type 2 diabetes

New collaboration could lead to novel drugs that address unmet medical needs

Increase in physical activity boosts breast cancer survivors’ mental processing speed

Salk study shows how fast-growing tumors evade immune system

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Arkansas professor makes strides toward developing enhanced cancer treatment

Woman's choice of surgeon plays major role in influencing breast cancer treatment choices

Immunotherapy could help some breast cancer patients based on genetic changes in their tumors

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Researchers reveal possible origin of cancer-associated fibroblasts

Study identifies late effects that may interfere with work status of young adult cancer survivors

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Existing drug may one day protect premenopausal women from infertility after cancer treatments

Why one California County went surgery shopping

Motorized molecules driven by light to cut into cancer cells

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News